wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38026956-11D87311-5197-4B97-83EE-BCF9CF5B708F
Q38026956-11D87311-5197-4B97-83EE-BCF9CF5B708F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38026956-11D87311-5197-4B97-83EE-BCF9CF5B708F
Recent advances in incretin-based therapies.
P2860
Q38026956-11D87311-5197-4B97-83EE-BCF9CF5B708F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38026956-11D87311-5197-4B97-83EE-BCF9CF5B708F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
106029e2de61fc37d7d299db5e5ea1e4915e9f1d
P2860
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study